Do Pharma Companiyon Mein KKR Ke Inavestameint Ko Manjoori

Business »

Do Pharma Companiyon Mein KKR Ke Inavestameint Ko Manjoori

[ iti bureau | nai Delhi ] sarkaar ne mangalvaar ko private ikviti farm kekeaar ke do dava companiyon- glaind pharma aur glaind selsas baayo chemicals mein stek khareedne ke prapojal ko apni manjoori de di. Is deal ke jariye total inavestameint inaflo 1,400 karod rupaye se jyaada ka hoga. Pablik helthakeyar chintaaon ke baavajood haaliya saalon mein faarmaasyutikls sector mein ise ek aur badi deal ke taur par dekha ja raha hai. Kekeaar ki yojana glaind pharma mein 37.9 feesadi stek 19.1 karod dollar (1,150 karod rupaye) mein khareedne ki hai. Saath hi ye glaind selsas baayo chemicals mein bhi 3.98 karod dollar (240 karod rupaye) mein 24.9 feesadi stek lena chaahati hai. Is deal ko kaumpiteeshan commission of India (seeseeaai) aur fauren inavestameint promotion board (efaaaipeebi) pehle hi apni hari jhandi dikha chuke hain. Kekeaar ne pichhle saal November mein glaind pharma aur glaind selsas ke saath share parachej egreemeint kiye the. Bade inavestameint mein kekeaar floralaain investments peeteei limited glaind pharma mein nae sheyaron ke sabsakripshan aur iaaielaesaef ko-inavest I elaelasi ke sheyaron ki parachej ke jariye 37.98 feesadi stek ki khareed karegi. Iaaielaesaef glaind pharma mein maujooda private ikviti inavestar hai. Doosare prapojal mein kekeaar glaind selsas baayo chemicals mein 24.9 feesadi stek khareedegi. Cabinet kleeyareins haasil karne vaale final prapojal mein naun-kanpeet klauj naheen hain, taaki braaunafeeld veinchars mein pharma FDI paulisi mein laae gaye nae niyamon ko poora kiya ja sake. Iska moolataur par matlab yeh hai ki glaind pharma ke pramotars isi tarah ke business ko fir se khada karne par share parachej egreemeint karne ke liye baadhya naheen honge. Glaind pharma davaaon ke jenerik varjans ke liye speshalaaijd injektebal faurmyuleshans banaati aur bechati hai. Yeh ektiv faarmaasyutikl inagrediyents (epeeaai) ki bhi seemit maatra in-house kanjampashan ke liye banaati hai. India ne otomaitik root ke tahat green field pharma projekts mein 100 feesadi FDI ki manjoori di hai. Lekin, braaunafeeld veinchars mein malteeneshanal companiyon ko inavestameint karne ke liye efaaaipeebi ki manjoori ki jaroorat hoti hai. Haaliya saalon mein deal vailyooeshan mein tej uchhaal aaya hai. 2008 mein daaichi ne rainabaiksi mein 63.5 feesadi stek lene ke liye 4.9 arab dollar chukaae the , yeh poora sauda cash mein hua tha. Isse rainabaiksi ki vailyooeshan 8.5 arab dollar baithi thi , jo ki 2007 mein iski enual sales ka paanch guna thi. Do saal baad ebaut ne piraamal ki unit ki khareed iski enual sales ke nau gune par vailyooeshan karte hu A ki.

Do Pharma Companiyon Mein KKR Ke Inavestameint Ko Manjoori https://www.angrejinews.com/pic/50505